Xu Yonggang, Hua Jin, Li Jipeng, Shi Liubin, Yuan Jie, Du Jianjun
Department of General Surgery, Huashan Hospital North, Fudan University, Shanghai, China.
Department of Surgery, Xijing Hospital of Digestive Diseases, The Fourth Military Medical University, Xian, China.
J Surg Res. 2017 Jul;215:190-195. doi: 10.1016/j.jss.2017.03.048. Epub 2017 Apr 7.
Laparoscopy-assisted gastrectomy (LAG) has already been introduced for advanced gastric cancer (AGC). However, little is known as to whether LAG is also applicable for AGC with serous invasion given the possibility that malignant cell dissemination and local recurrence incidence might increase. This study was designed to evaluate the technical feasibility and oncological adequacy of LAG in comparison with open gastrectomy (OG) for AGC with serous invasion.
A retrospective case-matched study was conducted to compare LAG and OG for AGC with serous invasion. For this study, 67 consecutive patients with AGC who underwent LAG between April 2007 and March 2011 were recruited and compared with 67 AGC patients who received OG during the same time period. We analyzed the patient demographics, operative results, pathologic characteristics, and long-term outcomes.
No significant differences were observed in the numbers of harvested lymph nodes (24.0 ± 8.2 versus 25.6 ± 8.8, P = 0.083) or the average distance between the proximal and distal resection margins (4.8 ± 2.5 cm versus 4.6 ± 2.4 cm, P = 0.354; 6.6 ± 4.2 cm versus 7.6 ± 4.7 cm, P = 0.105) in the LAG and OG groups. The complication rate was similar between the LAG and OG groups (6.0% versus 4.5%, P = 0.500). The duration of postoperative analgesic use was significantly shorter in the LAG group than in the OG group (2.9 ± 0.6 d versus 3.9 ± 0.6 d, P < 0.001). The 5-y cumulative survival and recurrence-free survival rates of the two groups were similar (31.3% versus 29.9%, P = 0.949; 29.9% versus 23.9%, P = 0.716).
The findings in this study suggest that LAG is a feasible and safe procedure for patients with seriously invasive AGC and predict acceptable long-term oncologic outcomes. LAG may be an appropriate choice to treat patients with seriously invasive AGC.
腹腔镜辅助胃切除术(LAG)已被应用于进展期胃癌(AGC)。然而,鉴于恶性细胞播散和局部复发发生率可能增加,对于伴有浆膜侵犯的AGC患者LAG是否也适用却知之甚少。本研究旨在评估LAG与开腹胃切除术(OG)相比,用于治疗伴有浆膜侵犯的AGC的技术可行性和肿瘤学疗效。
进行一项回顾性病例对照研究,比较LAG和OG治疗伴有浆膜侵犯的AGC的疗效。本研究纳入了2007年4月至2011年3月期间连续接受LAG的67例AGC患者,并与同期接受OG的67例AGC患者进行比较。我们分析了患者的人口统计学特征、手术结果、病理特征和长期预后。
LAG组和OG组在清扫淋巴结数量(24.0±8.2枚对25.6±8.8枚,P=0.083)或近端和远端切缘之间的平均距离(4.8±2.5cm对4.6±2.4cm,P=0.354;6.6±4.2cm对7.6±4.7cm,P=0.105)方面未观察到显著差异。LAG组和OG组的并发症发生率相似(6.0%对4.5%,P=0.500)。LAG组术后使用镇痛剂的时间明显短于OG组(2.9±0.6天对3.9±0.6天,P<0.001)。两组的5年累积生存率和无复发生存率相似(31.3%对29.9%,P=0.949;29.9%对23.9%,P=0.716)。
本研究结果表明,LAG对于伴有严重浆膜侵犯的AGC患者是一种可行且安全的手术方式,并预示着可接受的长期肿瘤学预后。LAG可能是治疗伴有严重浆膜侵犯的AGC患者的合适选择。